Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. (CoA, ORD_42780/2024, 5 September 2024)
| Date | 5 September 2024 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Appeal RoP220.2 |
| Registry reference | APL_12739/2024 · ORD_42780/2024 |
| Parties | Advanced Bionics Sarl , Advanced Bionics AG, Advanced Bionics GmbH v. MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 5 September 2024 (UPC_CoA_106/2024, APL_12739/2024), the Court of Appeal (K. Grabinski, presiding, P. Blok, rapporteur, E. Germano) dismissed Advanced Bionics’ appeal against the Mannheim Local Division’s order of 22 February 2024 refusing to transfer to the Central Division, for joint hearing with the revocation action filed on 27 September 2023, the infringement action on EP 4 074 373 brought by MED-EL on 2 November 2023. The order lays down two principles on the allocation of cases between divisions.
Question
Does joinder for connection under Rule 340 RoP, or Art. 33 UPCA, allow an infringement action to be transferred from a local division to the Central Division without the parties’ consent?
Decision
No. Rule 340 RoP cannot lead to a transfer outside the cases provided for in Art. 33 UPCA, which prevails over the Rules of Procedure under Art. 41(1) UPCA and Rule 1.1 RoP, Rule 340 itself requiring Art. 33 to be observed (paragraph 8). Art. 33(3)(c) UPCA allows an infringement action together with a counterclaim for revocation to be referred only with the parties’ agreement, and Art. 33(5) read with Art. 33(3) does not allow a transfer without consent either (paragraph 9). As MED-EL expressly objected, transfer was ruled out (paragraph 10). The risk of divergent claim construction does not alter this: the revocation action, which is further advanced, is likely to be decided first, the Mannheim panel can take it into account, and the defendants can draw its attention to the construction advanced by MED-EL before the Central Division (paragraph 11).
Key points for practice
- Practical point: a defendant that first brings a revocation action before the Central Division cannot force the patentee to have the infringement action heard there too, consistency is secured by taking account of whichever decision comes first.
Provisions applied
- Agreement on a Unified Patent Court
- Arts. 33(3) and (5) and 41(1)
- Rules of Procedure
- Rules 1.1 and 340
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.
Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- defendantMED-EL Elektromedizinische Geräte Gesellschaft m.b.H7 decisions in the corpusFollow this party
- claimantAdvanced Bionics AG7 decisions in the corpusFollow this party
- claimantAdvanced Bionics GmbH5 decisions in the corpusFollow this party
- claimantAdvanced Bionics Sarl5 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Appeal RoP220.2
- Outcome (Dhenne Avocats summary)
- La cour d'appel juge que ni la règle 340 ni l'article 33 de l'Accord ne permettent de renvoyer une action en contrefaçon d'une division locale à la division centrale sans l'accord des parties, et rejette l'appel.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 4 074 373mentioned in: Dhenne Avocats analysis Follow this patent
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.